AARTIDRUGS2023-07-012023-09-30 AARTIDRUGS2023-07-012023-09-30 AARTIDRUGS2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member AARTIDRUGS2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member AARTIDRUGS2023-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524348 AARTIDRUGS NOTLISTED Aarti Drugs Limited Equity 2023-04-01 2024-03-31 2023-10-19 2023-10-12 INR Lakhs Half yearly 12:00:00 15:40:00 2023-10-19 2023-10-19 true Cash Flow Indirect Not applicable Single segment Pharmaceuticals 2023-07-01 2023-09-30 Audited Standalone 5775400000.00 7400000.00 5782800000.00 3919700000.00 80700000.00 -86200000.00 200400000.00 75500000.00 117800000.00 1006600000.00 5314500000.00 468300000.00 0.00 468300000.00 110000000.00 12500000.00 122500000.00 0.00 345800000.00 0.00 0.00 0.00 0.00 345800000.00 0.00 345800000.00 345800000.00 0.00 919400000.00 10 3.75 3.75 0.00 0.00 3.75 3.75 For AARTI DRUGS LIMITED PRAKASH M. PATIL CHAIRMAN, MANAGING DIRECTOR & CEO DIN: 00005618 Place: Mumbai Date: 19th October 2023 Single segment 2023-04-01 2023-09-30 Audited Standalone 11691700000.00 13900000.00 11705600000.00 7909900000.00 193200000.00 -159000000.00 407000000.00 153200000.00 235300000.00 1967300000.00 10706900000.00 998700000.00 0.00 998700000.00 237500000.00 20000000.00 257500000.00 0.00 741200000.00 0.00 0.00 0.00 0.00 741200000.00 0.00 741200000.00 741200000.00 0.00 919400000.00 10 8.02 8.02 0.00 0.00 8.02 8.02 Other Expenses 1006600000.00 Other Expenses 1967300000.00 6272500000.00 2463200000.00 0.00 2600000.00 283300000.00 0.00 192800000.00 476100000.00 9214400000.00 4674000000.00 0.00 6514100000.00 27200000.00 0.00 0.00 115000000.00 6656300000.00 598900000.00 11929200000.00 21143600000.00 919400000.00 10233200000.00 11152600000.00 11152600000.00 1718800000.00 158100000.00 1876900000.00 55900000.00 703700000.00 2636500000.00 3262700000.00 3687300000.00 14100000.00 6964100000.00 378800000.00 11600000.00 7354500000.00 9991000000.00 21143600000.00 1)The above results for the quarter and Period ended 30th September, 2023 have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on 19th October, 2023. 2)The company has completed buyback of 6,65,000 equity shares of face value Rs.10/- representing up to 0.72% of the total number of Equity Shares of the Company at a price of Rs. 900/- per Equity Share (including premium of Rs. 890/- per Equity Share) payable in cash for an aggregate amount of up to Rs. 59,85,00,000/- (excluding transaction costs such as brokerage, Buyback tax, securities transaction tax, goods and service tax, stamp duty etc.)(“Buyback Size”) on 24th August, 2023 .Post buyback Paid up Share Capital of the Company reduced to Rs. 91,93,50,000 divided into 9,19,35,000 Equity Shares of Rs.10/- each. 3)Earnings per share for each of the three months ended 30 th September 2023 and 30 th June 2023 will not add up to earnings per share for the six months ended 30th September 2023,on account of Buyback of Equity shares. 4)Company has only one business segment i.e. pharmaceuticals. 5)Figures for the previous Quarter have been regrouped or rearranged wherever necessary. 6)The aforesaid Audited Financial Results will be uploaded on the Company's website www.aartidrugs.com and will also be available on the website of BSE Limited www.bseindia.com and the National Stock Exchange of India Limited www.nseindia.com for the benefit of the shareholders and investors. For AARTI DRUGS LIMITED PRAKASH M. PATIL CHAIRMAN, MANAGING DIRECTOR & CEO DIN: 00005618 Place: Mumbai Date: 19th October 2023 0.00 103300000.00 1451800000.00 0.00 0.00 0.00 0.00 0.00 0.00 -522600000.00 0.00 0.00 0.00 235300000.00 0.00 12200000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2900000.00 0.00 1282900000.00 2281600000.00 0.00 -153200000.00 -100000.00 252600000.00 0.00 2182100000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 985500000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100000.00 0.00 0.00 0.00 -985400000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 121100000.00 0.00 0.00 0.00 732300000.00 129400000.00 0.00 -455000000.00 -1195600000.00 1100000.00 0.00 1100000.00 21000000.00 22100000.00